Evidence map›Paper›PMID 34347569›Full record

ArticleGlobal health action2021

Knowledge among patients with Hepatitis C initiating on direct-acting antiviral treatment in rural Rwanda: A prospective cohort study.

Dale A Barnhart, Innocent Kamali, Francoise Nyirahabihirwe, Carol Mugabo, Jean de la Paix Gakuru, Mariam Uwase, Esdras Nizeyumuremyi, Tumusime Musafiri, Jean de Dieu Gatete, Jean Damascene Makuza and 3 more

Open access · goldAbstract read
In one paragraph

Article in Global health action, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Dale A BarnhartDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-0129-0313
Innocent KamaliPartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.ORCID 0000-0002-7772-6454
Francoise NyirahabihirwePartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Carol MugaboPartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Jean de la Paix GakuruPartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Mariam UwasePartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Esdras NizeyumuremyiPartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Tumusime MusafiriPartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Jean de Dieu GatetePartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Jean Damascene MakuzaSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-7904-1256
Fredrick KateeraPartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Bethany Hedt-GauthierDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Jean d'Amour NdahimanaPartners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Harvard University · USUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurative direct-acting antiviral treatment (DAA) has made it plausible to implement hepatitis C elimination interventions. However, poor hepatitis C knowledge among patients could impede the effectiveness of screening and treatment programs.

objectiveWe assessed knowledge on hepatitis C among rural Rwandans initiating DAA treatment for hepatitis C in a prospective cohort.

methodsWe administered 15 true-false statements before treatment initiation and during one follow-up visit occurring either 1 or 2 months after treatment initiation. We assessed the average number of correct responses per patient, the proportion of correct responses to individual statements, pre-treatment predictors of knowledge, and whether post-initiation knowledge was associated with time since treatment initiation, quality of care, or adherence.

resultsAmong 333 patients who answered knowledge questions before treatment initiation, 325 (97.6%) were re-assessed at a post-initiation visit. Pre-initiation, 72.1% knew hepatitis C was curable, 61.9% knew that hepatitis C could cause liver damage or cancer, and 42.3% knew that people with hepatitis C could look and feel fine. The average number of correct responses was 8.1 out of 15 (95% CI: 7.8-8.5), but was significantly lower among those with low educational attainment or with low literacy. Post-initiation, correct responses increased by an average of 2.0 statements (95% CI: 1.6, 2.4,

conclusionAlthough knowledge improved over time, key gaps persisted among patients. Accessible public education campaigns targeted to low-literacy populations emphasizing that hepatitis C can be asymptomatic, has severe consequences, and is curable could promote participation in mass screening campaigns and linkage to care. Visual tools could facilitate clinician-provided patient education.

Indexed as

Hepatitis CHepatitis C, ChronicAntiviral AgentsCohort StudiesHumansProspective StudiesRwandaAntiviral Agentsattitudesdirect acting antiviralshealth knowledgeHepatitis CpracticeRwandatreatment initiation

Identifiers

PMID34347569
PMCPMC8344237
OpenAlexW3187157597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.